SEC Form 4 reporting owner

Flynn James E

Flynn James E has filed 24 Form 4 transactions reported between February 27, 2026 and July 15, 2026, as Director of Nuvalent, Inc., 10% owner of Parabilis Medicines, Inc. and Director of Larimar Therapeutics, Inc..

Name as filed: Flynn James E

Open-market buys, 24 mo
$25.0M
4 lines
Open-market sales, 24 mo
None
reported
Companies
3
with Form 4 filings
Latest transaction
Jul 15, 2026
transaction date

Roles and reported holdings

  • NUVLNuvalent, Inc.
    Jun 16, 2026 – Jul 15, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • PBLSParabilis Medicines, Inc.
    Jun 11, 2026

    10% owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • LRMRLarimar Therapeutics, Inc.
    Feb 27, 2026 – May 19, 2026

    Director

    Held indirectly (latest line)6,207,982 sh as of Feb 27, 2026 · Form 4

    24 months: $25.0M bought

Transaction history

All 24 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect4,147—Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect3,789—Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect15,000—Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect20,000—Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect43,000—Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect2,717,627$337.0M@ $124.00Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect3,444$427K@ $124.00Form 4
Jul 15, 2026NUVLDirectorTender in change of controlCode U · indirect5,146$638K@ $124.00Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect650,000$80.6M@ $124.00Form 4
Jul 15, 2026NUVLDirectorDisposition to issuerCode D · indirect8,299,225$1.03B@ $124.00Form 4
Jun 16, 2026NUVLDirectorGrant or awardCode A · indirect3,444—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect464,550—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect246,732—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect143,650—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect166,070—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect407,132—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect260,992—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect149,238—Form 4
Jun 11, 2026PBLS10% ownerConversion of derivativeCode C · indirect122,990—Form 4
May 19, 2026LRMRDirectorGrant or awardCode A · indirect55,150—Form 4
Feb 27, 2026LRMRDirectorOpen-market purchaseCode P · indirect2,000,000$10.0M@ $5.00Form 4
Feb 27, 2026LRMRDirectorOpen-market purchaseCode P · indirect831,978$4.2M@ $5.00Form 4
Feb 27, 2026LRMRDirectorOpen-market purchaseCode P · indirect1,084,012$5.4M@ $5.00Form 4
Feb 27, 2026LRMRDirectorOpen-market purchaseCode P · indirect1,084,010$5.4M@ $5.00Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.